EcoDrugPlus

Bcl2 Like 1

Ensembl ID : ENSCAFG00020004231
Gene Symbol: BCL2L1
3 Cross references
289 Possible Orthologues:

Bcl2 Like 2

Ensembl ID : ENSCAFG00020006663
Gene Symbol: BCL2L2
3 Cross references
64 Possible Orthologues:

Bcl2 Related Protein A1

Ensembl ID : ENSCAFG00020015746
Gene Symbol: BCL2A1
3 Cross references
133 Possible Orthologues:

Bcr Activator Of Rhogef And Gtpase

Ensembl ID : ENSCAFG00020004820
Gene Symbol: BCR
3 Cross references
286 Possible Orthologues:

Bruton Tyrosine Kinase

Ensembl ID : ENSCAFG00020007390
Gene Symbol: BTK
3 Cross references
207 Possible Orthologues:

C-C Motif Chemokine Receptor 1

Ensembl ID : ENSCAFG00020013860
Gene Symbol: CCR1
3 Cross references
158 Possible Orthologues:

C-C Motif Chemokine Receptor 2

Ensembl ID : ENSCAFG00020013866
Gene Symbol: CCR2
3 Cross references
150 Possible Orthologues:

C-C Motif Chemokine Receptor 4

Ensembl ID : ENSCAFG00020002363
Gene Symbol: CCR4
3 Cross references
113 Possible Orthologues:

C-C Motif Chemokine Receptor 5

Ensembl ID : ENSCAFG00020013868
Gene Symbol: CCR5
3 Cross references
152 Possible Orthologues:

C-C Motif Chemokine Receptor 9

Ensembl ID : ENSCAFG00020013734
Gene Symbol: CCR9
3 Cross references
265 Possible Orthologues:

C-X-C Chemokine Receptor Type 2-Like

Ensembl ID : ENSCAFG00020027108
Gene Symbol: LOC112656593
2 Cross references
270 Possible Orthologues:

C-X-C Motif Chemokine Ligand 8

Ensembl ID : ENSCAFG00020026907
Gene Symbol: CXCL8
3 Cross references
179 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).